Main description:

Drug Delivery Trends examines a drift in the pharmaceutical field across the wide range of dosage forms, drug delivery systems (micro and nanoparticulate), at the regulatory front and on new types of therapies in the market. This volume additionally covers the challenges on drug delivery systems in terms of preclinical and current ways of determining quality and the options to solve the challenges associated with this. Most small-medium scale industries and academics struggle with initial regulatory challenges so a detailed discussion on regulatory trend covers the necessary basic understanding of regulatory procedures and provides the required guidance.

The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.

Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.

Contents:

1. Bioactive hybrid nanowires: a new in trend for site-speci?c drug delivery and targeting
A.R. FERNANDES, J. DIAS-FERREIRA, M.C. TEIXEIRA, A.A.M. SHIMOJO, PATRICIA SEVERINO, A.M. SILVA, RANJITA SHEGOKAR, AND ELIANA B. SOUTO
2. Opportunities and challenges of 3D-printed pharmaceutical dosage forms
ADAM PROCOPIO AND DIVYA TEWARI
3. Marketing authorization and licensing of medicinal products in EU: Regulatory aspects
MUHANED AL-HINDAWI
4. Clinical considerations on micro- and nanodrug delivery systems
PRAMIL TIWARI, VIVEK RANJAN SINHA, AND RANDEEP KAUR
5. Nanoparticulate treatments for oral delivery
ROHIT C. GHAN
6. Pharmaceutical mini-tablets: a revived trend
VENKAT TUMULURI
7. Liquid crystalline drug delivery systems
LUCIANA NALONE, CONRADO MARQUES, SALVANA COSTA, ELIANA B. SOUTO, AND PATRICIA SEVERINO
8. Amorphous drug stabilization using mesoporous materials
DANILLO F.M.C. VELOSO, MATTHIAS M. KNOPP, AND KORBINIAN LEUROOBMANN
9. "Quality" of pharmaceutical products for human usedunderlying concepts and required practices
SAEED A. QURESHI
10. Optimizing intraperitoneal drug delivery: pressurized intraperitoneal aerosol chemotherapy (PIPAC)
M.A. REYMOND AND A. KEUROONIGSRAINER
11. Upscaling and GMP production of pharmaceutical drug delivery systems
NAZENDE GEUROUNDAY TEUROURELI AND AKIF EMRE TEUROURELI